Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jun
13
2023
An “Overbroad” Noncompete – the NLRB Has Found Its First Target Epstein Becker & Green, P.C.
Jun
13
2023
Connecticut Health Care Bill Revises Provider-Payor Contracting Requirements to Address Competitive Concerns Robinson & Cole LLP
Jun
13
2023
Alabama Medical Cannabis Commission Announces Initial License Awards Bradley Arant Boult Cummings LLP
Jun
12
2023
Summary Judgment for Champion Petfoods Affirmed in Heavy Metals Class Action Lawsuit Keller and Heckman LLP
Jun
12
2023
American Beverage Association Comments on Plant-Based Milk Guidance Keller and Heckman LLP
Jun
12
2023
Kitchen Sink MDRP Proposed Rule Radically Changes Best Price Determination Resulting in Financial and Operational Challenges for Pharmaceutical Manufacturers ArentFox Schiff LLP
Jun
12
2023
New FDA Draft Guidance Updates Recommendations for Good Clinical Practices Nelson Mullins
Jun
12
2023
CMS Withdraws COVID-19 Vaccination Mandate, Enhances Focus on Quality Measures McDermott Will & Emery
Jun
11
2023
Workplace Strategies Watercooler 2023: TECHPLACE™ Talk—ChatGPT, Biometrics, and AI? Oh My! [Podcast] Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jun
11
2023
Is this “Good-Bye” to the Two-Year Mandatory Minimum in Healthcare Fraud Cases? Sheppard, Mullin, Richter & Hampton LLP
Jun
11
2023
Trending in Telehealth: May 31 – June 5, 2023 McDermott Will & Emery
Jun
10
2023
Second Circuit Approves Nonconsensual Third-Party Release in Purdue Pharma Case: Where Do Third Party Releases Stand Now? Hunton Andrews Kurth
Jun
9
2023
Remote Monitoring Services Under Review: Update on Potential Medicare Coverage Policies (May 2023 Update) McDermott Will & Emery
Jun
9
2023
Right-to-Weed States: Assessing Impairment and Managing Employee Conduct in the Workplace Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jun
9
2023
Connecticut Legislature Amends Physician Non-Compete Statute, Adds Protections for APRNs, PAs Jackson Lewis P.C.
Jun
9
2023
Tomato Troubles: NatureSweet Files Third Lawsuit Against Angel Sweet Over Product Packaging ArentFox Schiff LLP
Jun
9
2023
MCDERMOTTPLUS CHECK-UP: JUNE 9, 2023 McDermott Will & Emery
Jun
9
2023
FTC and DOJ Antitrust Memorialize Joint Workshop on the Future of Antitrust Enforcement in the Pharmaceutical Industry Mintz
Jun
9
2023
Old North State Report – June 5, 2023 Nelson Mullins
Jun
9
2023
Court Unseals Charges Alleging Nearly $15 Million in Fraudulent PPP Loans ArentFox Schiff LLP
Jun
9
2023
Connecticut Governor’s Health Care Bill Makes Important Changes to the Certificate of Need Process Robinson & Cole LLP
Jun
8
2023
EUON Posts Nanopinions on Using SWCNTs to Measure Biochemical Processes and on Experiments Involving Zebrafish to Elicit an Immune Response Bergeson & Campbell, P.C.
Jun
8
2023
Minnesota Becomes Second State To Pass Sweeping PFAS Ban and Reporting Law Targeting All Products Hunton Andrews Kurth
Jun
8
2023
Trademark Infringement is No Joke!: Jack Daniel’s Properties, Inc. v. VIP Products LLC Ward and Smith, P.A.
Jun
7
2023
GAO’s Priority Open Recommendations for EPA Include Recommendations Regarding the IRIS Program Bergeson & Campbell, P.C.
Jun
7
2023
The More You Claim, The More You Must Enable: SCOTUS Delivers Amgen v. Sanofi Opinion Dinsmore & Shohl LLP
Jun
7
2023
Supreme Court Again Tightens FCA Intent, But Tricky Questions Linger ArentFox Schiff LLP
Jun
7
2023
Bipartisan Lawmakers Seek to Remove Tariffs on Infant Formula with Proposed Formula 3.0 Act Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins